Integrated BioPharma's Plant-Produced Flu Subunit Vaccines Provide Protection in Preclinical Studies
April 30, 2008 12:10 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., April 30, 2008 (PRIME NEWSWIRE) -- InB:Biotechnologies, Inc., a wholly-owned subsidiary of Integrated BioPharma, Inc. (Nasdaq:INBP), announced today that prototypes of the Company's...
Integrated BioPharma, Inc. Complies With Marketplace Rule 4350
April 25, 2008 15:00 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., April 25, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that it is in compliance with Marketplace Rule 4350.
On February 21, 2008, the Company...
Integrated BioPharma Announces Appointments to Senior Management Group
February 26, 2008 14:02 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Feb. 26, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that Carl DeSantis, the founder, principal owner and former Chairman and CEO of Rexall...
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2007 and Announces New $17.5 Million Financing
February 22, 2008 16:23 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Feb. 22, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) reported financial results today for the three and six month periods ended December 31, 2007.
Revenues for...
Integrated Biopharma, Inc. Names Robert L. Erwin as President of InB:Biotechnologies, Inc.
November 14, 2007 13:15 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated Biopharma, Inc. (Nasdaq:INBP) today announced the appointment of Robert L. Erwin as President of its wholly-owned subsidiary,...
Integrated Biopharma Executes Spin-Off Agreement
November 14, 2007 12:45 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated Biopharma, Inc. (Nasdaq:INBP) announced today that its Board of Directors has approved the previously-announced spin-off of its...
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2007
November 14, 2007 12:10 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) reported financial results today for its first quarter ended September 30, 2007. Revenues for the quarter...
Integrated BioPharma Reports Results for Its Fiscal Year Ended June 30, 2007
September 28, 2007 17:00 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Sept. 28, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) reported financial results today for its fiscal year ended June 30, 2007. Revenues were $60.2 million, an...
Integrated BioPharma Announces SEC Approval to Withdraw Registration Statement
August 30, 2007 10:30 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Aug. 30, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced that the Securities and Exchange Commission (SEC) has approved the Company's application to...
Integrated BioPharma Announces Novel Platform Technology With Multiple Product Leads
August 14, 2007 09:30 ET
|
Integrated BioPharma, Inc.
HILLSIDE, N.J., Aug. 14, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced that its subsidiary, InB:Biotechnologies, Inc. (InB:Bio) has developed what it believes is a novel,...